Table 3

Questionnaires.

QuestionnairesMAD (n = 15)Placebo (n = 15)pgroup × timeEffect size
Baseline mean ± SD1.5-year mean ± SDBaseline mean ± SD1.5-year mean ± SD(d)
Epworth Sleepiness Scale13.2 ± 7.812.1 ± 8.911 ± 127.2 ± 8.0.32.45
Fatigue (MFIS)51 ± 24.535.3 ± 35.651.8 ± 46.948 ± 34.9.086.35
PSQI component 12.3 ± 1.72 ± 22 ± 22.2 ± 2.2.40.1
PSQI component 22 ± 1.31.8 ± 1.11.8 ± 1.71.5 ± 1.4.70.15
PSQI component 31.7 ± 1.41.9 ± 1.91.7 ± 1.51.6 ± 2.40.15
PSQI component 41.8 ± 1.11.1 ± 0.71.7 ± 0.92.2 ± 3.02*0.55
PSQI component 52.1 ± 1.31.8 ± 1.61.8 ± 1.51.7 ± 1.4.50.05
PSQI component 62.1 ± 1.41.6 ± 1.51.7 ± 1.71.8 ± 1.7.10.1
PSQI component 71.8 ± 1.31.8 ± 1.61.7 ± 1.91.7 ± 2.7.90.05
PSQI total12.9 ± 8.49.5 ± 8.19.7 ± 10.510.3 ± 12.03*0.4
FOSQ general productivity2.8 ± 23.2 ± 22.5 ± 2.63.1 ± 1.1.60.05
FOSQ social outcome3 ± 3.33.4 ± 32.5 ± 3.23.3 ± 2.6.50.05
FOSQ activity levela2.5 ± 23 ± 1.72.4 ± 1.63.3 ± 1.4.20.15
FOSQ vigilance2.6 ± 2.22.9 ± 1.92.8 ± 2.23.4 ± 1.4.60.25
FOSQ intimate relationships and sexual activity2.8 ± 3.83.3 ± 3.21.9 ± 2.52.5 ± 2.7.70.4
FOSQ totala13.3 ± 11.515.8 ± 10.212.1 ± 10.515.5 ± 7.7.60.15
Beck Anxiety Inventory16.9 ± 24.810.7 ± 1722.5 ± 33.420.3 ± 26.6.14.8
Beck Depression Inventory21.6 ± 18.610.8 ± 10.916.2 ± 21.514.4 ± 18.3<.01*1.8
QuestionnairesMAD (n = 15)Placebo (n = 15)pgroup × timeEffect size
Baseline mean ± SD1.5-year mean ± SDBaseline mean ± SD1.5-year mean ± SD(d)
Epworth Sleepiness Scale13.2 ± 7.812.1 ± 8.911 ± 127.2 ± 8.0.32.45
Fatigue (MFIS)51 ± 24.535.3 ± 35.651.8 ± 46.948 ± 34.9.086.35
PSQI component 12.3 ± 1.72 ± 22 ± 22.2 ± 2.2.40.1
PSQI component 22 ± 1.31.8 ± 1.11.8 ± 1.71.5 ± 1.4.70.15
PSQI component 31.7 ± 1.41.9 ± 1.91.7 ± 1.51.6 ± 2.40.15
PSQI component 41.8 ± 1.11.1 ± 0.71.7 ± 0.92.2 ± 3.02*0.55
PSQI component 52.1 ± 1.31.8 ± 1.61.8 ± 1.51.7 ± 1.4.50.05
PSQI component 62.1 ± 1.41.6 ± 1.51.7 ± 1.71.8 ± 1.7.10.1
PSQI component 71.8 ± 1.31.8 ± 1.61.7 ± 1.91.7 ± 2.7.90.05
PSQI total12.9 ± 8.49.5 ± 8.19.7 ± 10.510.3 ± 12.03*0.4
FOSQ general productivity2.8 ± 23.2 ± 22.5 ± 2.63.1 ± 1.1.60.05
FOSQ social outcome3 ± 3.33.4 ± 32.5 ± 3.23.3 ± 2.6.50.05
FOSQ activity levela2.5 ± 23 ± 1.72.4 ± 1.63.3 ± 1.4.20.15
FOSQ vigilance2.6 ± 2.22.9 ± 1.92.8 ± 2.23.4 ± 1.4.60.25
FOSQ intimate relationships and sexual activity2.8 ± 3.83.3 ± 3.21.9 ± 2.52.5 ± 2.7.70.4
FOSQ totala13.3 ± 11.515.8 ± 10.212.1 ± 10.515.5 ± 7.7.60.15
Beck Anxiety Inventory16.9 ± 24.810.7 ± 1722.5 ± 33.420.3 ± 26.6.14.8
Beck Depression Inventory21.6 ± 18.610.8 ± 10.916.2 ± 21.514.4 ± 18.3<.01*1.8

MAD = mandibular advancement device; MFIS = Modified Fatigue Impact Scale; PSQI = Pittsburgh Sleep Quality Index; FOSQ = Functional Outcomes of Sleep Questionnaire.

Data represented by mean ± standard deviation.

Generalized Estimation Equation (GEE) (time, group, interaction time × group), covariates: delta BMI (1.5-year treatment-baseline).

Effect size: Cohen’s d.

*p ≤ .05 interaction group (placebo and UARS) and time (baseline and after 1.5-year treatment).

ap ≤ .05 between time independently of group.

Table 3

Questionnaires.

QuestionnairesMAD (n = 15)Placebo (n = 15)pgroup × timeEffect size
Baseline mean ± SD1.5-year mean ± SDBaseline mean ± SD1.5-year mean ± SD(d)
Epworth Sleepiness Scale13.2 ± 7.812.1 ± 8.911 ± 127.2 ± 8.0.32.45
Fatigue (MFIS)51 ± 24.535.3 ± 35.651.8 ± 46.948 ± 34.9.086.35
PSQI component 12.3 ± 1.72 ± 22 ± 22.2 ± 2.2.40.1
PSQI component 22 ± 1.31.8 ± 1.11.8 ± 1.71.5 ± 1.4.70.15
PSQI component 31.7 ± 1.41.9 ± 1.91.7 ± 1.51.6 ± 2.40.15
PSQI component 41.8 ± 1.11.1 ± 0.71.7 ± 0.92.2 ± 3.02*0.55
PSQI component 52.1 ± 1.31.8 ± 1.61.8 ± 1.51.7 ± 1.4.50.05
PSQI component 62.1 ± 1.41.6 ± 1.51.7 ± 1.71.8 ± 1.7.10.1
PSQI component 71.8 ± 1.31.8 ± 1.61.7 ± 1.91.7 ± 2.7.90.05
PSQI total12.9 ± 8.49.5 ± 8.19.7 ± 10.510.3 ± 12.03*0.4
FOSQ general productivity2.8 ± 23.2 ± 22.5 ± 2.63.1 ± 1.1.60.05
FOSQ social outcome3 ± 3.33.4 ± 32.5 ± 3.23.3 ± 2.6.50.05
FOSQ activity levela2.5 ± 23 ± 1.72.4 ± 1.63.3 ± 1.4.20.15
FOSQ vigilance2.6 ± 2.22.9 ± 1.92.8 ± 2.23.4 ± 1.4.60.25
FOSQ intimate relationships and sexual activity2.8 ± 3.83.3 ± 3.21.9 ± 2.52.5 ± 2.7.70.4
FOSQ totala13.3 ± 11.515.8 ± 10.212.1 ± 10.515.5 ± 7.7.60.15
Beck Anxiety Inventory16.9 ± 24.810.7 ± 1722.5 ± 33.420.3 ± 26.6.14.8
Beck Depression Inventory21.6 ± 18.610.8 ± 10.916.2 ± 21.514.4 ± 18.3<.01*1.8
QuestionnairesMAD (n = 15)Placebo (n = 15)pgroup × timeEffect size
Baseline mean ± SD1.5-year mean ± SDBaseline mean ± SD1.5-year mean ± SD(d)
Epworth Sleepiness Scale13.2 ± 7.812.1 ± 8.911 ± 127.2 ± 8.0.32.45
Fatigue (MFIS)51 ± 24.535.3 ± 35.651.8 ± 46.948 ± 34.9.086.35
PSQI component 12.3 ± 1.72 ± 22 ± 22.2 ± 2.2.40.1
PSQI component 22 ± 1.31.8 ± 1.11.8 ± 1.71.5 ± 1.4.70.15
PSQI component 31.7 ± 1.41.9 ± 1.91.7 ± 1.51.6 ± 2.40.15
PSQI component 41.8 ± 1.11.1 ± 0.71.7 ± 0.92.2 ± 3.02*0.55
PSQI component 52.1 ± 1.31.8 ± 1.61.8 ± 1.51.7 ± 1.4.50.05
PSQI component 62.1 ± 1.41.6 ± 1.51.7 ± 1.71.8 ± 1.7.10.1
PSQI component 71.8 ± 1.31.8 ± 1.61.7 ± 1.91.7 ± 2.7.90.05
PSQI total12.9 ± 8.49.5 ± 8.19.7 ± 10.510.3 ± 12.03*0.4
FOSQ general productivity2.8 ± 23.2 ± 22.5 ± 2.63.1 ± 1.1.60.05
FOSQ social outcome3 ± 3.33.4 ± 32.5 ± 3.23.3 ± 2.6.50.05
FOSQ activity levela2.5 ± 23 ± 1.72.4 ± 1.63.3 ± 1.4.20.15
FOSQ vigilance2.6 ± 2.22.9 ± 1.92.8 ± 2.23.4 ± 1.4.60.25
FOSQ intimate relationships and sexual activity2.8 ± 3.83.3 ± 3.21.9 ± 2.52.5 ± 2.7.70.4
FOSQ totala13.3 ± 11.515.8 ± 10.212.1 ± 10.515.5 ± 7.7.60.15
Beck Anxiety Inventory16.9 ± 24.810.7 ± 1722.5 ± 33.420.3 ± 26.6.14.8
Beck Depression Inventory21.6 ± 18.610.8 ± 10.916.2 ± 21.514.4 ± 18.3<.01*1.8

MAD = mandibular advancement device; MFIS = Modified Fatigue Impact Scale; PSQI = Pittsburgh Sleep Quality Index; FOSQ = Functional Outcomes of Sleep Questionnaire.

Data represented by mean ± standard deviation.

Generalized Estimation Equation (GEE) (time, group, interaction time × group), covariates: delta BMI (1.5-year treatment-baseline).

Effect size: Cohen’s d.

*p ≤ .05 interaction group (placebo and UARS) and time (baseline and after 1.5-year treatment).

ap ≤ .05 between time independently of group.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close